WHO Department of Reproductive Health and Research. Vaginal bleeding in early pregnancy. In: Managing complications in pregnancy and childbirth: a guide for midwives and doctors. 2007. http://www.who.int (last accessed 24 November 2016).
Neilson JP, Gyte GM, Hickey M, et al. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2013;(3):CD007223.
American Congress of Obstetricians and Gynecologists. Practice bulletin: early pregnancy loss. May 2015. https://access.acog.org (last accessed 24 November 2016).
Tunçalp O, Gülmezoglu AM, Souza JP. Surgical procedures for evacuating incomplete miscarriage. Cochrane Database Syst Rev. 2010;(9):CD001993.
Jauniaux E, Farquharson RG, Christiansen OB, et al. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21:2216-2222.
Duckitt K, Qureshi A. Recurrent miscarriage. BMJ Clin Evid. 2015. http://clinicalevidence.bmj.com (last accessed 24 November 2016).
1. WHO Department of Reproductive Health and Research. Vaginal bleeding in early pregnancy. In: Managing complications in pregnancy and childbirth: a guide for midwives and doctors. 2007. http://www.who.int (last accessed 24 November 2016).
2. Hutchon DJ. Understanding miscarriage or insensitive abortion: time for more defined terminology? Am J Obstet Gynecol. 1998;179:397-398.
3. Association of Early Pregnancy Units. AEPU organisational, clinical and supportive guidelines. 2007. http://www.earlypregnancy.org.uk (last accessed 24 November 2016).
4. Makrydimas G, Sebire NJ, Lolis D, et al. Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation. Ultrasound Obstet Gynecol. 2003;22:368-372.
5. Ellish NJ, Saboda K, O'Connor J, et al. A prospective study of early pregnancy loss. Hum Reprod. 1996;11:406-412.
6. Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Ballieres Best Pract Res Clin Obstet Gynaecol. 2000;14:839-854.
7. Moore J, Shillito TJ, Walker JJ. Current issues in management of miscarriage and early pregnancy bleeding. Hosp Med. 2002;63:134-135.
8. Farr SL, Schieve LA, Jamieson DJ. Pregnancy loss among pregnancies conceived through assisted reproductive technology, United States, 1999-2002. Am J Epidemiol. 2007;185:1380-1388.
9. Topping J, Farquharson RG. Spontaneous miscarriage. In: Edmonds DK, ed. Dewhurst's textbook of obstetrics and gynaecology. Oxford, UK: Blackwell Publishing. 2007:94-99.
10. Ventura SJ, Abma JC, Mosher WD, et al. Estimated pregnancy rates for the United States, 1990-2000: an update. Natl Vital Stat Rep. 2004;52:1-9.
11. Blohm F, Friden B, Milsom I. A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population. BCOJ. 2007;115:176-183.
12. Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189-194.
13. Buckett W, Regan L. Sporadic and recurrent miscarriage. In: Shaw RW, Soutter WP, Stanton SL, eds. Gynaecology. 3rd ed. London, UK: Churchill Livingstone/ Elsevier Science; 2003:343-359.
14. Rizzi EL, Dalla-Zuanna G. The seasonality of conception. Demography. 2007;44:705-728.
15. Vitzthum VJ, Spielvogel H, Thornburg J. A prospective study of early pregnancy loss in humans. Fertil Steril. 2006;86:373-379.
16. Morales C, Sanchez A, Bruquera J, et al. Cytogenetic studies of spontaneous abortions using semi-direct analysis of chorionic villi samples detects the broadest spectrum of chromosome abnormalities. Am J Med Genet A. 2008;146A:66-70.
17. Vidal F, Rubio C, Simon C, et al. Is there a place for preimplantation genetic diagnosis screening in recurrent miscarriage patients? J Reprod Fertil Suppl. 2000;55:143-146.
18. Sullivan AE, Lewis T, Stephenson M, et al. Pregnancy outcome in recurrent miscarriage patients with skewed X chromosome inactivation. Obstet Gynecol. 2003;101:1236-1242.
19. Pasquier E, Bohec C, De Saint Martin L, et al. Strong evidence that skewed X-chromosome inactivation is not associated with recurrent pregnancy loss: an incident paired case-control study. Hum Reprod. 2007;22:2829-2833.
20. Miskovic S, Culic V, Konjevoda P, et al. Positive reproductive family history for spontaneous abortion: predictor for recurrent miscarriage in young couples. Eur J Obstet Gynecol Reprod Biol. 2012;161:182-186.
21. Ugwumadu A . Chorioamnionitis and mid-trimester pregnancy loss. Gynecol Obstet Invest. 2010;70:281-285.
22. Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Obstet Gynecol. 2007;21:375-390.
23. Nelson DB, Bellamy S, Nachamkin I, et al. First trimester bacterial vaginosis, individual microorganism levels and risk of second trimester pregnancy loss among urban women. Fertil Steril. 2007;88:1396-1403.
24. Empson M, Lassere M, Craig J, et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005;(2):CD002859.
25. Ernst E. Herbal medicinal products during pregnancy: are they safe? BJOG. 2002;109:227-235.
26. Akolekar R, Bower S, Flack N, et al. Prediction of miscarriage and stillbirth at 11-13 weeks and the contribution of chorionic villus sampling. Prenatal Diagn. 2011;31:38-45.
27. Vailhe B, Dietl J, Kapp M, et al. Increased blood vessel density in decidua parietalis is associated with spontaneous human first trimester abortion. Hum Reprod. 1999;14:1628-1634.
28. Sherer DM, Abulafia O. Angiogenesis during implantation and placental and early embryonic development. Placenta. 2001;22:1-13.
29. Kwak-Kim JY, Chung-Bang HS, Ng SC, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses, and infertile women with multiple implantation failure after IVF. Hum Reprod. 2003;18:767-773.
30. King K, Smith S, Chapman M, et al. Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage. Hum Reprod. 2010;25:52-58.
31. Teklenburg G, Salker M, Heijnen C, et al. The molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod. 2010;16:886-895.
32. Nybo Andersen AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320:1708-1712.
33. de la Rochebrochard E, Thonneau P. Paternal age and maternal age are risk factors for miscarriage: results of a multicentre European study. Hum Reprod. 2002;17:1649-1656.
34. ESHRE Capri Workshop Group. Genetic aspects of female reproduction. Hum Reprod Update. 2008;14:293-307.
35. Garcia-Enguidanos A, Calle ME, Valero J, et al. Risk factors in miscarriage: a review. Eur J Obstet Gynecol Reprod Biol. 2002;102:111-119.
36. Nelen WL, Blom HJ, Steegers EA, et al. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril. 2000;74:1196-1199.
37. Royal College of Obstetricians and Gynaecologists. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. Green-top guideline no.17. April 2011. http://www.rcog.org.uk (last accessed 24 November 2016).
38. Sun Y, Che Y, Gao E, et al. Induced abortion and risk of subsequent miscarriage. Int J Epidemiol. 2003;32:449-454.
39. Virk J, Zhang J, Olsen J. Medical abortion and the risk of subsequent adverse pregnancy outcomes. N Engl J Med. 2007;357:648-653.
40. Gray RH, Wu LY. Subfertility and risk of spontaneous abortion. Am J Public Health. 2000;90:1452-1454.
41. Axmon A, Hagmar L. Time to pregnancy and pregnancy outcome. Fertil Steril. 2005;84:966-974.
42. Shi Q, Martin RH. Aneuploidy in human spermatozoa: FISH analysis in men with constitutional chromosomal abnormalities in infertile men. Reproduction. 2001;121:655-666.
43. Nielsen GL, Skriver MV, Pedersen L, et al. Danish group reanalyses miscarriage in NSAID users. BMJ. 2004;328:109.
44. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. 2003;327:368.
45. Anderson BL, Juliano LM, Schulkin J. Caffeine's implications for women’s health and survey of obstetrician-gynecologists’ caffeine knowledge and assessment practices. J Womens Health. 2009;18:1457-1466.
46. Cnattigius S, Signorello LB, Anneren G, et al. Caffeine intake and the risk of first trimester spontaneous abortion. N Engl J Med. 2000;343:1839-1845.
47. Savitz DA, Chan RL, Herring AH, et al. Caffeine and miscarriage risk. Epidemiology. 2008;19:55-62.
48. Henderson J, Gray R, Brocklehurst P. Systematic review of effects of low moderate alcohol exposure in pregnancy outcome. BJOG. 2007;114:243-252.
49. Tolstrup JS, Kjaer SK, Munk C, et al. Does caffeine and alcohol intake before pregnancy predict the occurrence of spontaneous abortion? Hum Reprod. 2003;18:2704-2710.
50. Nielsen A, Hannibal CG, Lindekilde BE, et al. Maternal smoking predicts the risk of spontaneous abortion. Acta Obstet Gynecol Scand. 2006;85:1057-1065.
51. Venners SA, Wang X, Chen C, et al. Paternal smoking and pregnancy loss: a prospective study using a biomarker of pregnancy. Am J Epidemiol. 2004;159:993-1001.
52. Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004;19:1644-1646.
53. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2543-2565.
54. Lepoutre T, Debiève F, Gruson D, et al. Reduction of miscarriages through universal screening and treatment of thyroid autoimmune diseases. Gynecol Obstet Invest. 2012;74:265-273.
55. Agnesi R, Valentini F, Fedeli U, et al. Maternal exposures and risk of spontaneous abortion before and after a community oriented health education campaign. Eur J Public Health. 2011;21:282-285.
56. Balogun OO, da Silva Lopes K, Ota E, et al. Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev. 2016;(5):CD004073.
57. Aleman A, Althabe F, Belizán JM, et al. Bed rest during pregnancy for preventing miscarriage. Cochrane Database Syst Rev. 2005;(2):CD003576.
58. Mattox KL, Goetzl L. Trauma in pregnancy. Crit Care Med. 2005;33(suppl 10):385-389.
59. Hoey R, Allan K. Does speculum examination have a role in assessing bleeding in early pregnancy? Emerg Med J. 2004;21:461-463.
60. Tong S, Wallace EM, Rombauts L. Association between low day 16 hCG and miscarriage after proven cardiac activity. Obstet Gynecol. 2006;107:300-304.
61. Condous G, Okaro E, Bourne T. The conservative management of early pregnancy complications: a review of the literature. Ultrasound Obstet Gynecol. 2003;22:420-430.
62. Kadar N, Caldwell BV, Romero R. A method of screening for ectopic pregnancy and its indications. Obstet Gynecol. 1981;58:162-166.
63. National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management. December 2012. https://www.nice.org.uk/CG154 (last accessed 24 November 2016).
64. Duan L, Yan D, Zeng W, et al. Predictive power progesterone combined with beta human chorionic gonadotropin measurements in the outcome of threatened miscarriage. Arch Gynecol Obstet. 2011;283:431-435.
65. Verhaegen J, Gallos ID, van Mello NM, et al. Accuracy of single progesterone test to predict early pregnancy outcome in women with pain or bleeding: meta-analysis of cohort studies. BMJ. 2012;345:e6077.
66. Barnhart KT, Simhan H, Kamelle SA. Diagnostic accuracy of ultrasound above and below the beta-hCG discriminatory zone. Obstet Gynecol. 1999;94:583-587.
67. Abdallah Y, Daemen A, Kirk E, et al. Limitations of current definitions of miscarriage using mean gestational sac diameter and crown-rump length measurements: a multicenter observational study. Ultrasound Obstet Gynecol. 2011;38:497-502.
68. Bourne T, Bottomley C. When is a pregnancy nonviable and what criteria should be used to define miscarriage? Fertil Steril. 2012;98:1091-1096.
69. Preisler J, Kopeika J, Ismail L, et al. Defining safe criteria to diagnose miscarriage: prospective observational multicentre study. BMJ. 2015;351:h4579.
70. Bottomley C, Van Belle V, Kirk E, et al. Accurate prediction of pregnancy viability by means of a simple scoring system. Hum Reprod. 2013;28:68-76.
71. Dhillon RK, Hillman SC, Morris RK, et al. Additional information from chromosomal microarray analysis (CMA) over conventional karyotyping when diagnosing chromosomal abnormalities in miscarriage: a systematic review and meta-analysis. BJOG. 2014;121:11-21.
72. Yang J, Savitz DA, Dole N, et al. Predictors of vaginal bleeding during the first two trimesters of pregnancy. Paediatr Perinat Epidemiol. 2005;19:276-283.
73. Gracia CR, Sammel MD, Chittams J, et al. Risk factors for spontaneous abortion in early symptomatic first-trimester pregnancies. Obstet Gynecol. 2005;106:993-999.
74. Maconochie N, Doyle P, Prior S, et al. Risk factors for first trimester miscarriage-results from a UK-population-based case-control study. BCOJ. 2007;114:170-186.
75. Ouyang DW, Economy KE, Norwitz ER. Obstetric complication of fibroids. Obstet Gynecol Clin North Am. 2006;33:153-169.
76. Sagili H, Mohamed K. Pregnancy of unknown location: an evidence-based approach to management. The Obstetrician and Gynaecologist. 2008;10:224-230
77. Farquharson RG, Jauniaux E, Exalto N; ESHRE Special Interest Group for Early Pregnancy (SIGEP). Updated and revised nomenclature for description of early pregnancy events. Hum Reprod. 2005;20:3008-3011.
78. Chittacharoen A, Herabutya Y. Slow fetal heart rate may predict pregnancy outcome in first trimester threatened abortion. Fertil Steril. 2004;82:227-229.
79. Noble G, Harvey C, Napier C, et al. Preimplantation genetic screening in advanced maternal age: a systematic review. Expert Rev Obstet Gynecol. 2010;5:707-716.
80. Papaioannou GI, Syngelaki A, Maiz N, et al. Ultrasonographic prediction of early miscarriage. Hum Reprod. 2011;26:1685-1692.
81. Edey K, Draycott T, Akande VA. Early pregnancy assessment units. Clin Obstet Gynecol. 2007;50:146-153.
82. Cahill DJ, Wardle PG. Bleeding and pain in early pregnancy. In: James DK, Steer PJ, Weiner CP, et al., eds. High risk pregnancy, management options. 3rd ed. Pennsylvania: Elsevier-Saunders; 2006:84-104.
83. Saraswat L, Bhattacharya S, Maheshwari A, et al. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG. 2010;117:245-257.
84. Neilson JP, Gyte GM, Hickey M, et al. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2013;(3):CD007223.
85. American Congress of Obstetricians and Gynecologists. Practice bulletin: early pregnancy loss. May 2015. https://access.acog.org (last accessed 24 November 2016).
86. Luise C, Jermy K, May C, et al. Outcome of expectant management of spontaneous first trimester miscarriage: observational study. BMJ. 2002;324:873-875.
87. Shelley JM, Healy D, Grover S. A randomized trial of surgical, medical and expectant management of first trimester miscarriage. Aust N Z J Obstet Gynaecol. 2005;45:122-127.
88. Rulin MC, Bornstein SG, Campbell JD. The reliability of ultrasonography in the management of spontaneous abortion, clinically thought to be complete: a prospective study. Am J Obstet Gynecol. 1993;168:12-15.
89. Ballagh SA, Harris HA, Demasio K. Is curettage needed for uncomplicated incomplete spontaneous abortion? Am J Obstet Gynecol. 1998;179:1279-1282.
90. Sawyer E, Ofuasia E, Ofili-Yebovi D, et al. The value of measuring endometrial thickness and volume on transvaginal ultrasound scan for the diagnosis of incomplete miscarriage. Ultrasound Obstet Gynecol. 2007;29:205-209.
91. Harwood B, Nansel T, National Institute of Child Health and Human Development Management of Early Pregnancy Failure Trial. Quality of life and acceptability of medical versus surgical management of early pregnancy failure. BJOG. 2008;115:501-508.
92. Nanda K, Lopez LM, Grimes DA, et al. Expectant care versus surgical treatment for miscarriage. Cochrane Database Syst Rev. 2012;(3):CD003518.
93. Smith LF, Ewings PD, Quinlan C. Incidence of pregnancy after expectant, medical or surgical management of spontaneous first trimester miscarriage: long-term follow-up of miscarriage treatment (MIST) randomised controlled trial. BMJ. 2009;339:b3827.
94. Davis AR, Hendlish SK, Westhoff C, et al. Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trial. Am J Obstet Gynecol. 2007;196:e1-e7.
95. Casikar I, Bignardi T, Riemke J, et al. Expectant management of spontaneous first-trimester miscarriage: prospective validation of the '2-week rule'. Ultrasound Obstet Gynecol. 2010;35:223-227.
96. Verkuyl DA, Crowther CA. Suction v. conventional curettage in incomplete abortion. A randomized controlled trial. S Afr Med J. 1993;83:13-15.
97. Tunçalp O, Gülmezoglu AM, Souza JP. Surgical procedures for evacuating incomplete miscarriage. Cochrane Database Syst Rev. 2010;(9):CD001993.
98. Sagili H, Divers M. Modern management of miscarriage. TOG Obstetrician Gynaecologist. 2007;9:102-108.
99. Creinin MD, Harwood B, Guido RS, et al. Endometrial thickness after misoprostol use for early pregnancy failure. Int J Gynaecol Obstet. 2004;86:22-26.
100. Trinder J, Brocklehurst P, Porter R, et al. Management of miscarriage: expectant, medical or surgical? Results of randomized controlled trial (miscarriage treatment (MIST) trial. BMJ. 2006;332:1235-1240.
101. Ngoc NT, Blum J, Westheimer E, et al. Medical treatment of missed abortion using misoprostol. Int J Gynaecol Obstet. 2004;87:138-142.
102. May W, Gülmezoglu AM, Ba-Thike K. Antibiotics for incomplete abortion. Cochrane Database Syst Rev. 2007(4):CD001779.
103. Achilles SL, Reeves MF; Society of Family Planning. Prevention of infection after induced abortion: release date October 2010: SFP guideline 20102. Contraception. 2011;83:295-309.
104. Savaris RF, de Moraes GS, Cristovam RA, et al. Are antibiotics necessary after 48 hours of improvement in infected/septic abortions? A randomized controlled trial followed by a cohort study. Am J Obstet Gynecol. 2011;204:301.e1-301.e5.
105. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod. 1999;14:2868-2871.
106. Saravelos SH, Li TC. Unexplained recurrent miscarriage: how can we explain it? Hum Reprod. 2012;27:1882-1886.
107. Jauniaux E, Farquharson RG, Christiansen OB, et al. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21:2216-2222.
108. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2013;(10):CD003511.
109. Kaandorp SP, Goddijn M, van der Post JA, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med. 2010;362:1586-1596.
110. Greer IA. Antithrombotic therapy for recurrent miscarriage? N Engl J Med. 2010;362:1630-1631.
111. Skeith L, Carrier M, Kaaja R, et al. A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia. Blood. 2016;127:1650-1655.
112. Wong LF, Porter TF, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2014;(10):CD000112.
113. Karanth L, Jaafar SH, Kanagasabai S, et al. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev. 2013;(3):CD009617.
114. Qureshi H, Massey E, Kirwan D, et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014;24:8-20.
115. Swanson KM, Chen HT, Graham JC, et al. Resolution of depression and grief during the first year after miscarriage: A randomized controlled clinical trial of couples-focused interventions. J Womens Health (Larchmt). 2009;18:1245-1257.
116. Peel E. Pregnancy loss in lesbian and bisexual women: an online survey of experiences. Hum Reprod. 2010;25:721-727.
117. Bique C, Ustá M, Debora B, et al. Comparison of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion. Int J Gynecol Obstet. 2007;98:222-226.
118. Duckitt K, Qureshi A. Recurrent miscarriage. BMJ Clin Evid. 2015. http://clinicalevidence.bmj.com (last accessed 24 November 2016).
119. Duan L, Yan D, Zeng W, et al. Effect of progesterone treatment due to threatened abortion in early pregnancy for obstetric and perinatal outcomes. Early Hum Dev. 2010;86:41-43.
120. Coomarasamy A, Williams H, Truchanowicz E, et al. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation. Health Technol Assess. 2016;20:1-92.
121. Tanha FD, Feizi M, Shariat M. Sublingual versus vaginal misoprostol for the management of missed abortion. J Obstet Gynaecol Res. 2010;36:525-532.
122. Diop A, Raghavan S, Rakotovao JP, et al. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial. Contraception. 2009;79:456-462.
123. Chen H, Fu J, Huang W. Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history. Cochrane Database Syst Rev. 2016;(7):CD008883.
124. Lykke JA, Dideriksen KL, Lidegaard O, et al. First-trimester vaginal bleeding and complications later in pregnancy. Obstet Gynecol. 2010;115:935-944.
125. Yael K, Lorenza P, Evelina S, et al. Incidental endometrial adenocarcinoma in early pregnancy: a case report and review of the literature. Int J Gynecol Cancer. 2009;19:1580-1584.
126. Lee C, Slade P, Lygo V. The influence of psychological debriefing on emotional adaptation in women following early miscarriage: a preliminary study. Br J Med Psychol. 1996;69:47-58.
127. Nikcevic AV, Kuczmierczyk AR, Nicolaides KH. The influence of medical and psychological interventions on women's distress after miscarriage. J Psychosom Res. 2007;63:283-290.
128. Murphy FA. The experiences of early miscarriage from a male perspective. J Clin Nurs. 1998;7:325-332.
129. Cumming GP, Klein S, Bolsover D, et al. The emotional burden of miscarriage for women and their partners: trajectories of anxiety and depression over 13 months. BJOG. 2007;114:1138-1145.
130. Neugebauer R, Kline J, Shrout P, et al. Major depressive disorder in the 6 months after miscarriage. JAMA. 1997;277:383-388.
131. Lok IH, Yip AS, Lee DT, et al. A 1-year longitudinal study of psychological morbidity after miscarriage. Fertil Steril. 2010;93:1966-1975.
132. Capella-Allouc S, Morsad F, Rongieres-Bertrand C, et al. Hysteroscopic treatment of severe Asherman’s syndrome and subsequent fertility. Hum Reprod. 1999;14:1230-1233.
133. Webber K, Grivell RM. Cervical ripening before first trimester surgical evacuation for non-viable pregnancy. Cochrane Database Syst Rev. 2015;(11):CD009954.
134. Hodgson DT, Loftipour S, Fox JC. Vaginal bleeding before 20 weeks gestation due to placental abruption leading to disseminated intravascular coagulation and fetal loss after appearing to satisfy criteria for routine threatened abortion: a case report and brief review of the literature. J Emerg Med. 2007;32:387-392.
135. Vlaanderen W, Fabriek LM, van Tuyll van Serooskerken C. Abortion risk and pregnancy interval. Acta Obstet Gynecol Scand. 1988;67:139-140.
136. Ali SM, Hecht BR. Attempting pregnancy after miscarriage and curettage - what is the minimum interval? Int J Gynecol Obstet. 1994;45:275-279.
137. Go KJ, Patel JC, Cunningham DL. The role of assisted reproductive technology in the management of recurrent pregnancy loss. Curr Opin Endocrinol Diabetes Obes. 2009;16:459-463.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台